{"schema_version":"secwatch.filing_event.v1","accession":"0000081362-23-000013","form_type":"8-K","ticker":"KWR","cik":"0000081362","company_name":"QUAKER CHEMICAL CORP","filed_at":"2023-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.160712+00:00","generated_at":"2026-06-19T03:38:56.961342+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Quaker Houghton Q4 net loss $76M on $93M goodwill impairment; non-GAAP EPS $1.39","bullets":["Q4 net sales $484.8M (+8% YoY) driven by 24% price/mix; volumes down 10%.","Full year 2022 net sales record $1.94B; net loss $15.9M vs net income $121.4M in 2021.","Non-GAAP Q4 EPS $1.39 vs $1.29 YoY; adjusted EBITDA $67.9M (+12% YoY).","EMEA segment goodwill impairment of $93M due to inflation, rising rates, Ukraine war.","Operating cash flow $68.1M in Q4; net debt to adjusted EBITDA 3.0x at year-end."],"urls":{"canonical":"https://secwatch.observer/filing/0000081362-23-000013","json":"https://secwatch.observer/filing/0000081362-23-000013.json","markdown":"https://secwatch.observer/filing/0000081362-23-000013.md","text":"https://secwatch.observer/filing/0000081362-23-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/81362/000008136223000013/0000081362-23-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/81362/000008136223000013/kwr-20230223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T03:38:56.961342+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6c50f0df9090e6e02ead1f5b77e8e1ced64f596e","claim":"QUAKER CHEMICAL CORP reported twelve months ended December 31, 2022 results: revenue $1.9 billion, net income (15,931), EPS (0.89).","evidence_excerpt":"FOURTH QUARTER AND FULL YEAR 2022 RESULTS • Q4’22 net sales of $484.8 million increased 8% compared to Q4’21 driven by higher selling prices • Record full year 2022 net sales of $1.9 billion primarily driven by value-based pricing initiatives • Q4’22 net loss of $76.0 million and net loss per diluted share of $4.24 which includes a $93.0 million impairment charge •","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/81362/000008136223000013/0000081362-23-000013-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"twelve months ended December 31, 2022"},{"label":"Revenue","value":"$1.9 billion"},{"label":"Net income","value":"(15,931)"},{"label":"EPS","value":"(0.89)"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"dac918c5cd1b003fd06f0a84e312639ee3130f57","claim":"QUAKER CHEMICAL CORP reported three months ended December 31, 2022 results: revenue $484.8 million, net income $76.0 million, EPS $4.24.","evidence_excerpt":"Q4’22 net sales of $484.8 million increased 8% compared to Q4’21 driven by higher selling prices • Record full year 2022 net sales of $1.9 billion primarily driven by value-based pricing initiatives • Q4’22 net loss of $76.0 million and net loss per diluted share of $4.24 which includes a $93.0 million impairment charge","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/81362/000008136223000013/0000081362-23-000013-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended December 31, 2022"},{"label":"Revenue","value":"$484.8 million"},{"label":"Net income","value":"$76.0 million"},{"label":"EPS","value":"$4.24"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}